Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
September 10 2024 - 4:09PM
Edgar (US Regulatory)
Barclays Bank
PLC has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission
(“SEC”) for the offering to which this free writing prospectus relates. Before you invest, you
should read the prospectus dated May 23, 2022, the prospectus supplement dated June 27, 2022 and the underlying
supplement dated June 27, 2022 and other documents Barclays Bank PLC has filed with the SEC for more complete
information about Barclays Bank PLC and this offering. You may get these documents and other documents Barclays
Bank PLC has filed for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, Barclays Bank
PLC or any agent or dealer participating in this offering will arrange to send you each of these documents
if you request them by calling your Barclays Bank PLC sales representative, such dealer or toll-free 1-888-227-2275
(Extension 2-3430). A copy of each of these documents may be obtained from Barclays Capital Inc., 745 Seventh
Avenue—Attn: US InvSol Support, New York, NY 10019.
|
Free writing prospectus
dated September 10, 2024 (to the Prospectus dated May 23, 2022, the Prospectus Supplement dated June 27, 2022 and the Underlying
Supplement dated June 27, 2022) |
Filed
Pursuant to Rule 433
Registration
Statement No. 333-265158 |
Barclays Bank PLC – Contingent Income Callable Securities due
September 21, 2034 Based on the Value of the S&P 500® Index
This document provides a summary of
the terms of the securities. Investors must carefully review the accompanying pricing supplement, the prospectus, prospectus supplement
and underlying supplement, as well as the “Risk Factors” on the following page, prior to making an investment decision.
Summary Terms |
|
Hypothetical Payment at Maturity* |
Issuer: |
Barclays
Bank PLC |
Underlier: |
S&P
500® Index (Bloomberg ticker symbol “SPX <Index>”) |
Pricing date: |
September
18, 2024 |
Original issue
date: |
September
23, 2024 |
Maturity date: |
September
21, 2034 |
Optional early
redemption: |
The
securities will not be redeemed prior to the March 21, 2025 contingent payment date. On any contingent payment date (other than the
final contingent payment date), beginning March 21, 2025, we will have the right to redeem the securities, in whole, but not in part,
at our discretion, for the early redemption payment. If we decide to redeem the securities on a contingent payment date after the
initial six-month non-call period, we will give you notice on or before the immediately preceding determination date. Any early redemption
of the securities will be at our discretion and will not automatically occur based on the performance of the underlier. |
Early
redemption payment: |
An
amount per security equal to (i) the stated principal amount plus (ii) any contingent quarterly payment otherwise due |
Contingent
quarterly payment: |
·
If,
on any determination date, the closing level of the underlier is greater than or equal to the downside threshold level, we
will pay a contingent quarterly payment of at least $18.625 (at least 1.8625% of the stated principal amount) per security on the
related contingent payment date.
·
If,
on any determination date, the closing level of the underlier is less than the downside threshold level, no contingent quarterly
payment will be made with respect to that determination date. |
Payment at maturity: |
If the securities are not redeemed
prior to maturity, you will receive on the maturity date a cash payment per security determined as follows:
·
If
the final underlier value is greater than or equal to the downside threshold level:
(i)
stated principal amount plus (ii) the contingent quarterly payment otherwise due
·
If
the final underlier value is less than the downside threshold level:
stated
principal amount × underlier performance factor
Under these circumstances, the
payment at maturity will be less than the stated principal amount of $1,000 and will represent a loss of more than 25%, and possibly
all, of an investor’s initial investment. Investors may lose their entire initial investment in the securities. |
Downside
threshold level: |
75%
of the initial underlier value (rounded to three decimal places) |
Initial
underlier value: |
The
closing level of the underlier on the pricing date |
Final
underlier value: |
The
closing level of the underlier on the final determination date |
Underlier
performance factor: |
final
underlier value / initial underlier value |
Determination
dates: |
Quarterly,
as specified in the accompanying pricing supplement |
Contingent
payment dates: |
Quarterly,
as specified in the accompanying pricing supplement |
CUSIP/ISIN: |
06745UYV6
/ US06745UYV69 |
Additional
terms: |
Terms
used in this document, but not defined herein, will have the meanings ascribed to them in the accompanying pricing supplement. |
Pricing
supplement: |
http://www.sec.gov/Archives/edgar/data/312070/000095010324013399/dp217864_424b2-6369ms.htm |
Payment
on the securities is not guaranteed by any third party and is subject to the creditworthiness of Barclays Bank PLC and the risk of
exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority. |
Change
in the Underlier |
Payment at
Maturity |
Total
Return on Securities |
50.00% |
$1,000.00 |
0.00% |
40.00% |
$1,000.00 |
0.00% |
30.00% |
$1,000.00 |
0.00% |
20.00% |
$1,000.00 |
0.00% |
10.00% |
$1,000.00 |
0.00% |
0.00% |
$1,000.00 |
0.00% |
-5.00% |
$1,000.00 |
0.00% |
-10.00% |
$1,000.00 |
0.00% |
-20.00% |
$1,000.00 |
0.00% |
-25.00% |
$1,000.00 |
0.00% |
-25.01% |
$749.90 |
-25.01% |
-30.00% |
$700.00 |
-30.00% |
-40.00% |
$600.00 |
-40.00% |
-50.00% |
$500.00 |
-50.00% |
-60.00% |
$400.00 |
-60.00% |
-70.00% |
$300.00 |
-70.00% |
-80.00% |
$200.00 |
-80.00% |
-90.00% |
$100.00 |
-90.00% |
-100.00% |
$0.00 |
-100.00% |
*The
table above assumes the securities are not redeemed prior to maturity and excludes any contingent quarterly payment otherwise due. |
Our estimated value of the securities
on the pricing date, based on our internal pricing models, is expected to be between $932.10 and $972.10 per security. The estimated
value is expected to be less than the initial issue price of the securities. See “Additional Information Regarding Our Estimated
Value of the Securities” in the accompanying pricing supplement.
U.K. Bail-in Power Acknowledgment:
Notwithstanding and to the exclusion of any other term of the securities
or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the securities
(or the trustee on behalf of the holders of the securities), by acquiring the securities, each holder and beneficial owner of the securities
acknowledges, accepts, agrees to be bound by and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority.
The Underlier
For more information about the underlier, including historical performance
information, see the accompanying pricing supplement.
Risk Factors
An investment in the securities involves significant risks. We urge
you to consult your investment, legal, tax, accounting and other advisors before you invest in the securities. Some of the risks that
apply to an investment in the securities are summarized below, but we urge you to read the more detailed explanation of risks relating
to the securities generally in the “Risk Factors” sections in the accompanying pricing supplement and the prospectus supplement.
You should not purchase the securities unless you understand and can bear the risks of investing in the securities.
Risks Relating to the Securities
Generally
| · | The securities do not guarantee the return of any principal. |
| · | You will not receive any contingent quarterly payment for
any quarterly period where the closing level of the underlier on the applicable determination date is less than the downside threshold
level. |
| · | You will not participate in any appreciation in the value
of the underlier. |
| · | The securities are subject to early redemption risk. |
| · | Any payment on the securities will be determined based on
the closing levels of the underlier on the dates specified. |
| · | Contingent repayment of principal applies only at maturity
or upon any early redemption. |
| · | The securities are subject to volatility
risk. |
| · | Investing in the securities is not equivalent to investing
in the securities composing the underlier. |
| · | Significant aspects of the tax treatment of the securities
are uncertain. |
Risks Relating to the Issuer
| · | Any payments on the securities are subject to issuer credit
risk. |
| · | You may lose some or all of your investment if any U.K. Bail-in
Power is exercised by the relevant U.K. resolution authority. |
Risks Relating to the Underlier
| · | Adjustments to the underlier could adversely affect the value
of the securities. |
| · | Governmental legislative or regulatory actions, such as sanctions,
could adversely affect your investment in the securities. |
Risks Relating to Conflicts
of Interest
| · | Hedging and trading activity by the issuer and its affiliates
could potentially adversely affect the value of the securities. |
| · | We and our affiliates, and any dealer participating in the
distribution of the securities, may engage in various activities or make determinations that could materially affect your securities in
various ways and create conflicts of interest. |
Risks Relating to the Estimated
Value of the Securities and the Secondary Market
| · | The securities will not be listed on any securities exchange,
and secondary trading may be limited. |
| · | The market price of the securities will be influenced by
many unpredictable factors. |
| · | The estimated value of your securities is expected to be
lower than the initial issue price of your securities. |
| · | The estimated value of your securities might be lower if
such estimated value were based on the levels at which our debt securities trade in the secondary market. |
| · | The estimated value of the securities is based on our internal
pricing models, which may prove to be inaccurate and may be different from the pricing models of other financial institutions. |
| · | The estimated value of your securities is not a prediction
of the prices at which you may sell your securities in the secondary market, if any, and such secondary market prices, if any, will likely
be lower than the initial issue price of your securities and may be lower than the estimated value of your securities. |
| · | The temporary price at which we may initially buy the securities
in the secondary market and the value we may initially use for customer account statements, if we provide any customer account statements
at all, may not be indicative of future prices of your securities. |
Tax Considerations
You should review carefully the section entitled “Additional Information
about the Securities—Tax considerations” in the accompanying pricing supplement.
In the event that any of the terms set forth or defined in this document
conflict with the terms or defined terms set forth in the accompanying pricing supplement, the terms or defined terms set forth in the
accompanying pricing supplement will control.
iPath Series B S&P 500 V... (AMEX:VXZ)
Historical Stock Chart
From Sep 2024 to Oct 2024
iPath Series B S&P 500 V... (AMEX:VXZ)
Historical Stock Chart
From Oct 2023 to Oct 2024